This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Simpson, J. F. Articles by Clarke, P. E. Search for Related Content PubMed PubMed Citation Articles by Simpson, J. F. Articles by Clarke, P. E.

American Journal of Pathology, Vol 151, 161-168, Copyright © 1997 by American Society for Investigative Pathology

REGULAR ARTICLES

Amplification of CCND1 and expression of its protein product, cyclin D1, in ductal carcinoma in situ of the breast

JF Simpson, DE Quan, F O'Malley, T Odom-Maryon and PE Clarke
Division of Pathology, City of Hope National Medical Center, Duarte, California, USA.

Ductal carcinoma in situ (DCIS) of the breast is a heterogeneous disease clinically and biologically. The few available studies of its natural history implicate DCIS as a non-obligate precursor for invasive carcinoma. We have used fluorescence in situ hybridization (FISH) to detect gene amplification of the cell cycle regulator gene CCND1 in 88 examples of formalin-fixed, paraffin-embedded DCIS. Expression of its protein product cyclin D1 was detected by immunohistochemistry. CCND1 was amplified in 18% of DCIS cases. High grade DCIS was more likely to show amplification than low grade DCIS (32% versus 8%; P = 0.08). Gene amplification was associated with cyclin D1 protein expression (P = 0.001), although cyclin D1 was detected in cases that did not demonstrate gene amplification. Overall, cyclin D1 protein was detected in 50% of DCIS cases. Although only 2 of 23 (8%) cases of low grade DCIS had CCND1 amplification, over 50% (13/23) of these cases expressed cyclin D1 protein. Low grade DCIS had a higher mean percentage of nuclei expressing cyclin D1 than did intermediate or high grade DCIS (P = 0.007). Mechanisms other than gene amplification may be responsible for increased cyclin D1 protein in DCIS, especially in low grade DCIS. Identifying mechanisms that control cell cycle progression in DCIS may yield clues to its biological behavior.

This article has been cited by other articles:

				R. E. Ellsworth, D. L. Ellsworth, B. Love, H. L. Patney, L. R. Hoffman, J. Kane, J. A. Hooke, and C. D. Shriver Correlation of Levels and Patterns of Genomic Instability With Histological Grading of DCIS Ann. Surg. Oncol., November 1, 2007; 14(11): 3070 - 3077. [Abstract] [Full Text] [PDF]

				Q. Zhou, P. Fukushima, W. DeGraff, J. B. Mitchell, M. Stetler-Stevenson, A. Ashkenazi, and P. S. Steeg Radiation and the Apo2L/TRAIL Apoptotic Pathway Preferentially Inhibit the Colonization of Premalignant Human Breast Cells Overexpressing Cyclin D1 Cancer Res., May 1, 2000; 60(10): 2611 - 2615. [Abstract] [Full Text]

				P. Schraml, J. Kononen, L. Bubendorf, H. Moch, H. Bissig, A. Nocito, M. J. Mihatsch, O.-P. Kallioniemi, and G. Sauter Tissue Microarrays for Gene Amplification Surveys in Many Different Tumor Types Clin. Cancer Res., August 1, 1999; 5(8): 1966 - 1975. [Abstract] [Full Text] [PDF]